# Mexiletine for the Treatment of Muscle Cramps in ALS

> **NCT01811355** · PHASE4 · COMPLETED · sponsor: **Bjorn Oskarsson, MD** · enrollment: 23 (actual)

## Conditions studied

- Muscle Cramps in Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** Mexiletine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01811355
- **Lead sponsor:** Bjorn Oskarsson, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2016-03
- **Final completion:** 2016-05
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2017-08-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01811355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01811355, "Mexiletine for the Treatment of Muscle Cramps in ALS". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01811355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*